Page last updated: 2024-08-21

benzoxazoles and hydrazine

benzoxazoles has been researched along with hydrazine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leistner, S; Wagner, G1
Carter, GW; Haviv, F; Kim, KH; Martin, YC; Young, PR1
Carter, GW; DeNet, RW; Haviv, F; Holms, JH; Kerdesky, FA; Ratajczyk, JD; Schmidt, SP; Walters, RL; Young, PR1
Hara, H; Morimoto, N; Nagai, H; Shimazawa, M; Yamashima, T1
Manjunatha, H; Rajesh, KP; Satyendra, RV; Shruthi, A; Vagdevi, HM; Vishnumurthy, KA1
Azevedo, RA; Barbuto, JA; de Sá Junior, PL; Farias, CF; Ferreira, AC; Ferreira, AK; Figueiredo, CR; Jorge, SD; Kruyt, FA; Palace-Berl, F; Pasqualoto, KF; Rodrigues, CP; Salomón, MA; Tavares, LC; Turra, KM1

Other Studies

6 other study(ies) available for benzoxazoles and hydrazine

ArticleYear
[Effect of amines and hydrazines on benzoxazolinone and benzoxazolinthione].
    Die Pharmazie, 1976, Volume: 31, Issue:6

    Topics: Amines; Benzoxazoles; Hydrazines; Phenylhydrazines; Thiones

1976
Inhibitors of immune complex-induced inflammation: 5-substituted 3-[1-(2-benzoxazolyl)hydrazino]propanenitrile derivatives.
    Journal of pharmaceutical sciences, 1990, Volume: 79, Issue:8

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthus Reaction; Benzoxazoles; Exudates and Transudates; Hydrazines; Immune Complex Diseases; Inflammation; Leukocyte Count; Male; Nitriles; Rats; Structure-Activity Relationship

1990
3-[1-(2-Benzoxazolyl)hydrazino]propanenitrile derivatives: inhibitors of immune complex induced inflammation.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:9

    Topics: Animals; Anti-Inflammatory Agents; Arthus Reaction; Benzoxazoles; Chemical Phenomena; Chemistry; Hydrazines; Hydrocortisone; Immune Complex Diseases; Indomethacin; Male; Nitriles; Pleural Diseases; Rats; Skin Diseases; Structure-Activity Relationship

1988
Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage.
    Brain research, 2005, May-17, Volume: 1044, Issue:1

    Topics: Animals; Antioxidants; Benzimidazoles; Benzoxazoles; Biphenyl Compounds; Brain Edema; Brain Infarction; Cell Death; Cell Survival; Cells, Cultured; Cerebral Cortex; Chromans; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Fluorescent Dyes; Glutamic Acid; Hydrazines; Infarction, Middle Cerebral Artery; Inhibitory Concentration 50; Ischemia; Lipid Peroxidation; Male; Mice; Minocycline; Neurons; Neuroprotective Agents; Oxidative Stress; Picrates; Quinolinium Compounds; Saponins; Tetrazolium Salts; Time Factors

2005
Synthesis, in vitro antioxidant, anthelmintic and molecular docking studies of novel dichloro substituted benzoxazole-triazolo-thione derivatives.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:7

    Topics: Animals; Annelida; Anthelmintics; Antioxidants; Benzoxazoles; Biphenyl Compounds; Chlorides; Helminth Proteins; Hydrazines; Molecular Docking Simulation; Picrates; Structure-Activity Relationship; Thermodynamics; Thiones; Triazoles; Tubulin; Tubulin Modulators

2011
BFD-22 a new potential inhibitor of BRAF inhibits the metastasis of B16F10 melanoma cells and simultaneously increased the tumor immunogenicity.
    Toxicology and applied pharmacology, 2016, Mar-15, Volume: 295

    Topics: Animals; Apoptosis; Benzoxazoles; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase 4; Flow Cytometry; Hydrazines; Melanoma, Experimental; Mice; Microscopy, Fluorescence; Molecular Docking Simulation; Oxadiazoles; Proto-Oncogene Proteins B-raf

2016